Long-Term Dysphagia Severity in Patients With Idiopathic Inflammatory Myopathy: A Single-Center Retrospective Study. [PDF]
Ohmura SI +3 more
europepmc +1 more source
Efficacy and Safety of Subcutaneous Abatacept Plus Standard Treatment for Active Idiopathic Inflammatory Myopathy: Phase 3 Randomized Controlled Trial. [PDF]
Aggarwal R +5 more
europepmc +1 more source
Belimumab treatment of adult idiopathic inflammatory myopathy. [PDF]
Marder G +9 more
europepmc +1 more source
Disease characteristics and medications use in idiopathic inflammatory myopathy: a multi-centre prospective observational study of decentralized remote vs. traditional clinic enrolment. [PDF]
Keret S +8 more
europepmc +1 more source
Contribution of major histocompatibility complex class II immunostaining in distinguishing idiopathic inflammatory myopathy subgroups: A histopathological cohort study. [PDF]
Lessard LER +10 more
europepmc +1 more source
Development of a machine learning model in prediction of the rapid progression of interstitial lung disease in patients with idiopathic inflammatory myopathy. [PDF]
Qiang Y +12 more
europepmc +1 more source
Related searches:
To discuss the clinical, laboratory, and histopathologic features and presumed pathogenic mechanisms of the four major categories of idiopathic inflammatory myopathy, namely dermatomyositis, polymyositis, immune-mediated necrotizing myopathy, and inclusion body myositis.Dermatomyositis, polymyositis, necrotizing myopathy, and inclusion body myositis ...
Anthony A, Amato, Steven A, Greenberg
openaire +4 more sources
Primary myositis (or inflammatory myopathies) comprises three main groups of diseases, based on clinical and immunohistochemical characteristics: polymyositis (PM), dermatomyositis (DM) and inclusion body myositis. Their clinical presentation and course are disparate, but a common characteristic is immune dysfunction-related inflammation of the ...
Patrick M., Grogan, Jonathan S., Katz
openaire +5 more sources

